Manuel Álvarez
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Metal complexes synthesis and properties
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
- Hepatology top 5%
Papers in
-
- Cancer therapeutics and mechanisms 6
- Epigenetics and DNA Methylation 4
- Genomics and Chromatin Dynamics 4
- Oncology 13
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Tito Fojo (3 shared papers)R. R. Parker (1 shared paper)Waldo Ortuzar (1 shared paper)Eddie Reed (1 shared paper)Olivier Rixe (1 shared paper)K Paull (1 shared paper)Susan E. Bates (8 shared papers)Robinson González (6 shared papers)
- Journals
- Blood (3 papers)Breast Cancer Research and Treatment (2 papers)Transfusion (2 papers)BMC Cancer (2 papers)The Oncologist (1 paper)
- Partner nations
- ChileUnited StatesSpain
In The Last Decade
Manuel Álvarez
60 papers receiving 2.1k citations
Manuel Álvarez's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 787
- Hepatology 129
- Epidemiology 366
- Molecular Biology 721
- Cancer Research 132
Countries citing papers authored by Manuel Álvarez
This map shows the geographic impact of Manuel Álvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Álvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Álvarez more than expected).
Fields of papers citing papers by Manuel Álvarez
This network shows the impact of papers produced by Manuel Álvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Álvarez. The network helps show where Manuel Álvarez may publish in the future.
Co-authors
The 25 scholars most cited alongside Manuel Álvarez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel Hit paper breakdown → | 1996 | 529 |
| 2 | 2006 | 138 | |
| 3 | 1998 | 134 | |
| 4 | 2008 | 110 | |
| 5 | 1992 | 81 | |
| 6 | 2009 | 73 | |
| 7 | Normal p53 status and function despite the development of drug resistance in human breast cancer cells. | 1995 | 69 |
| 8 | 2013 | 62 | |
| 9 | 1991 | 59 | |
| 10 | One-Session Management of Cervical Intraepithelial Neoplasia: A Solution for Developing Countries. A Prospective, Randomized Trial of LEEP versus Laser Excisional Conization | 1996 | 59 |
| 11 | 2005 | 58 | |
| 12 | 2002 | 57 | |
| 13 | 2017 | 52 | |
| 14 | 2008 | 50 | |
| 15 | 1996 | 50 | |
| 16 | 2012 | 49 | |
| 17 | 2005 | 46 | |
| 18 | 1995 | 42 | |
| 19 | 2014 | 36 | |
| 20 | 2004 | 31 |
About Manuel Álvarez
Manuel Álvarez is a scholar working on Molecular Biology, Oncology, Epidemiology, Pulmonary and Respiratory Medicine and Surgery, having authored 64 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (7 papers), BRCA gene mutations in cancer (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Cancer therapeutics and mechanisms (6 papers), Epigenetics and DNA Methylation (4 papers), Genomics and Chromatin Dynamics (4 papers), Hepatitis C virus research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (787 citations), Hepatology (129 citations), Epidemiology (366 citations), Molecular Biology (721 citations) and Cancer Research (132 citations). Manuel Álvarez has collaborated with scholars based in Chile, United States and Spain. Frequent co-authors include Tito Fojo, R. R. Parker, Waldo Ortuzar, Eddie Reed, Olivier Rixe, K Paull, Susan E. Bates, Robinson González, Antonio Tito Fojo and Rosa María Pérez‐Ayuso. Their work appears in journals such as Blood, Breast Cancer Research and Treatment, Transfusion, BMC Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.